tirzepatide and blood pressure medicine Tirzepatide is the #1 weight

For patients whose primary goal is significant weight loss, Ozempic-class medications consistently outperform SGLT2 inhibitors

Does a higher dose mean stronger side effects

Its phase 2 data, published in the New England Journal of Medicine in 2023, showed about 24% weight loss at the highest dose over 48 weeks, and later phase 3 results pushed toward 28%

In the end, the evidence brings us back full circle: the patient knows best, and their perspective must remain the foundation upon which tolerability, as part of truly patient-centered drug development, is built

If a male fetus inherits the mutant TMLHE gene, it will be unable to produce its own carnitine and will rely on the mother for its carnitine supply

This means it works by mimicking a natural hormone in the body called GLP-1 (glucagon-like peptide-1)